AVELOX- moxifloxacin hydrochloride injection, solution 
AVELOX- moxifloxacin hydrochloride tablet, film coated United States - English - NLM (National Library of Medicine)

avelox- moxifloxacin hydrochloride injection, solution avelox- moxifloxacin hydrochloride tablet, film coated

schering plough corporation - moxifloxacin hydrochloride (unii: c53598599t) (moxifloxacin - unii:u188xyd42p) - moxifloxacin 400 mg in 250 ml - avelox is indicated in adult patients for the treatment of community acquired pneumonia caused by susceptible isolates of streptococcus pneumoniae (including multi-drug resistant streptococcus pneumoniae [mdrsp]), haemophilus influenzae, moraxella catarrhalis, methicillin-susceptible staphylococcus aureus, klebsiella pneumoniae, mycoplasma pneumoniae, or chlamydophila pneumoniae [see clinical studies (14.3 )] . mdrsp isolates are isolates resistant to two or more of the following antibacterial drugs: penicillin (minimum inhibitory concentrations [mic] ≥ 2 mcg/ml), 2nd generation cephalosporins (for example, cefuroxime), macrolides, tetracyclines, and trimethoprim/sulfamethoxazole. avelox is indicated in adult patients for the treatment of uncomplicated skin and skin structure infections caused by susceptible isolates of methicillin-susceptible staphylococcus aureus or streptococcus pyogenes [see clinical studies (14.4 )]. avelox is indicated in adult patients for the treatment of complicated skin and ski

Dexadreson New Zealand - English - Ministry for Primary Industries

dexadreson

schering-plough animal health limited - dexamethasone - dexamethasone 2 g/litre - endocrine agent (hormone)

ESTRUMATE New Zealand - English - Ministry for Primary Industries

estrumate

schering-plough animal health limited - cloprostenol sodium - cloprostenol sodium 0.25 g/litre - endocrine agent (hormone)

Intron-A New Zealand - English - Medsafe (Medicines Safety Authority)

intron-a

schering-plough a division of schering-plough animal health limited - interferon alfa-2b 5 miu/ml;   - solution for injection - 5 miu/ml - active: interferon alfa-2b 5 miu/ml   excipient: albumin dibasic sodium phosphate glycine methyl hydroxybenzoate monobasic sodium phosphate monohydrate propyl hydroxybenzoate water for injection

AFRIN 0.05% nasal spray Egypt - English - EDA (Egyptian Drug Authority)

afrin 0.05% nasal spray

schering-plough corporation-usa - nasal spray - 0.05 %

CLARITINE 1mg/ml syrup Egypt - English - EDA (Egyptian Drug Authority)

claritine 1mg/ml syrup

schering-plough corporation-usa - syrup - 1 mg/ml

CLARITINE 10mg tab. Egypt - English - EDA (Egyptian Drug Authority)

claritine 10mg tab.

schering-plough corporation-usa - tablet - 10 mg

CLARITINE 10mg tab. Egypt - English - EDA (Egyptian Drug Authority)

claritine 10mg tab.

schering-plough corporation-usa - tablet - 10 mg